2,784 results on '"Abraham, William T."'
Search Results
2. Heart Failure Drug Development Over the Eras: From the Heart Failure Collaboratory
3. Design and Rationale of the V-Wave Shunt MitraClip Study
4. Pulmonary Vein Systolic Flow Reversal and Outcomes in Patients From the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (COAPT) Trial
5. Left Atrial Improvement in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial
6. Training the Next Generation of Data Monitoring Committee Members: An Initiative of the Heart Failure Collaboratory
7. Repeat Mitral Valve Interventions After Transcatheter Edge-to-Edge Repair: The COAPT Trial
8. Clinical Trial Inclusion and Impact on Early Adoption of Medical Innovation in Diverse Populations
9. Relationship between sex, body size, and cardiac resynchronization therapy benefit: A patient-level meta-analysis of randomized controlled trials
10. Ancillary procedures
11. Telemedicine and remote monitoring in heart failure
12. Changes in Left Ventricular Function and Outcomes After Trancatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation
13. Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping
14. Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials JACC Review Topic of the Week
15. Cross-Validation of Risk Scores for Patients Undergoing Transcatheter Edge-to-Edge Repair for Mitral Regurgitation
16. Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies: HF-ARC Expert Panel Paper
17. Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysis
18. Hemodynamic Monitoring Devices in the Management of Outpatient Heart Failure
19. Impact of Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial
20. Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation: The COAPT Trial
21. Cerebrovascular Events After Transcatheter Edge-to-Edge Repair and Guideline-Directed Medical Therapy in the COAPT Trial
22. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
23. Ventricular Remodeling and Outcomes After Mitral Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial
24. Abstract 17715: Heart Rate Reduction Alone Produces Reverse Remodeling in Heart Failure Patients Refractory to Beta-Blockers: The PROBE-IT Trial
25. Abstract 13402: Outcomes of Cardiac Resynchronization Therapy in Ischemic versus Non-Ischemic Cardiomyopathy: A Patient-Level Meta-Analysis of 7 Randomized Clinical Trials
26. Abstract 12936: Quality of Life Assessments as Inclusion Criteria in Heart Failure Clinical Trials
27. Percutaneous repair of moderate‐to‐severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE‐HF2 trial and comparison to COAPT and MITRA‐FR trials
28. Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert Panel
29. Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial
30. Minimally Clinically Important Difference in Health Status Scores in Patients With HFrEF vs HFpEF
31. Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?
32. Transcatheter Mitral Valve Replacement Versus Medical Therapy for Secondary Mitral Regurgitation: A Propensity Score–Matched Comparison
33. The V-LAP System for Remote Left Atrial Pressure Monitoring of Patients With Heart Failure: Remote Left Atrial Pressure Monitoring
34. Clinical Outcomes Related to Background Diuretic Use and New Diuretic Initiation in Patients With HFrEF
35. A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study
36. The importance of early evaluation after cardiac resynchronization therapy to redefine response: Pooled individual patient analysis from 5 prospective studies
37. Artificial Intelligence in Cardiovascular Clinical Trials.
38. In vivo fluid dynamics of the Ventura interatrial shunt device in patients with heart failure.
39. Dose-limiting, adverse event–associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial
40. Remote Speech Analysis in the Evaluation of Hospitalized Patients With Acute Decompensated Heart Failure
41. Risk Factor Burden, Heart Failure, and Survival in Women of Different Ethnic Groups: Insights From the Women's Health Initiative.
42. Enhancing Sweat Rate for In-Hospital and Home-Based Decongestive Therapy
43. Repeat Mitral Valve Interventions After Transcatheter Edge-to-Edge Repair:The COAPT Trial
44. Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long‐term outcomes
45. Interatrial shunt therapy in advanced heart failure: Outcomes from the open‐label cohort of the RELIEVE‐HF trial
46. Direct Interstitial Decongestion in an Animal Model of Acute-on-Chronic Ischemic Heart Failure
47. Pulmonary Artery Pressure Monitoring Effectively Guides Management to Reduce Heart Failure Hospitalizations in Obesity
48. Cardiac Resynchronization Therapy and Cardiac Contractility Modulation in Patients with Advanced Heart Failure: How to Select the Right Candidate?
49. Prognostic Importance of Health Status Versus Functional Status in Heart Failure and Secondary Mitral Regurgitation
50. Sex-Specific Outcomes of Transcatheter Mitral-Valve Repair and Medical Therapy for Mitral Regurgitation in Heart Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.